# BOK Financial Corp: overview

BOKF · Nasdaq · CIK 875357 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bokf.md) · [Financials](/companies/bokf/financials.md) · [Filings](/companies/bokf/filings.md) · [Insiders](/companies/bokf/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [2.18](/filings/0000875357-25-000057.md) | not reported | [1.86](/filings/0000875357-26-000034.md) | [2.19](/filings/0000875357-26-000048.md) | [2.22](/filings/0000875357-25-000057.md) | not reported | [2.58](/filings/0000875357-26-000034.md) | [2.92](/filings/0000875357-26-000048.md) |
| Free cash flow | $m | [210 d](/filings/0000875357-25-000057.md) | [494 d](/filings/0000875357-26-000013.md) | [(28.0)](/filings/0000875357-26-000034.md) | [60.8 d](/filings/0000875357-26-000048.md) | [839 d](/filings/0000875357-25-000057.md) | [(296) d](/filings/0000875357-26-000013.md) | [(284)](/filings/0000875357-26-000034.md) | [1,076 d](/filings/0000875357-26-000048.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [8.95](/filings/0000875357-24-000008.md) | [7.68](/filings/0000875357-25-000013.md) | [8.02](/filings/0000875357-26-000013.md) | [8.14](/filings/0000875357-26-000013.md) | [9.17](/filings/0000875357-26-000013.md) |
| Free cash flow | $m | [(3,897)](/filings/0000875357-24-000008.md) | [4,907](/filings/0000875357-25-000013.md) | [(99.7)](/filings/0000875357-26-000013.md) | [1,259](/filings/0000875357-26-000013.md) | [575](/filings/0000875357-26-000013.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bokf/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [George Kaiser Family Foundation](/funds/1265376.md) | 2026-06-30 | $466.9m | 3,361,707 |  | Unchanged |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $378.6m | 2,726,300 |  | Added +17,775 |
| [ARIEL INVESTMENTS, LLC](/funds/936753.md) | 2026-06-30 | $226.0m | 1,627,416 |  | Reduced −22,467 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $188.0m | 1,353,708 |  | Reduced −64,482 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $157.3m | 1,132,893 |  | Added +16,000 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $137.3m | 988,598 |  | Added +41 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $130.6m | 940,022 |  | Reduced −29,392 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $120.1m | 864,458 |  | Added +9,066 |
| [ELEVATION POINT WEALTH PARTNERS, LLC](/funds/1744349.md) | 2026-06-30 | $106.9m | 770,026 |  | New +770,026 |
| [Vestmark Advisory Solutions, Inc.](/funds/1736982.md) | 2026-06-30 | $106.9m | 770,021 |  | New +770,021 |

## Recent filings

[All 2,600 filings](/companies/bokf/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 20:06 ET | [8-K](/filings/0000875357-26-000054.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000875357-26-000054 |
| 2026-08-31 | 15:00 ET | [8-K](/filings/0000875357-26-000051.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000875357-26-000051 |
| 2026-08-04 | 17:20 ET | [10-Q](/filings/0000875357-26-000048.md) | Quarterly report, period 2026-06-30 | 0000875357-26-000048 |
| 2026-07-20 | 20:14 ET | [8-K](/filings/0000875357-26-000045.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000875357-26-000045 |
| 2026-05-11 | 16:59 ET | [8-K](/filings/0000875357-26-000038.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000875357-26-000038 |
| 2026-05-07 | 16:00 ET | [8-K](/filings/0000875357-26-000036.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000875357-26-000036 |
| 2026-05-06 | 16:05 ET | [10-Q](/filings/0000875357-26-000034.md) | Quarterly report, period 2026-03-31 | 0000875357-26-000034 |
| 2026-04-20 | 20:03 ET | [8-K](/filings/0000875357-26-000031.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000875357-26-000031 |
| 2026-04-06 | 20:19 ET | [8-K](/filings/0000875357-26-000028.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000875357-26-000028 |
| 2026-03-19 | 20:09 ET | [DEF 14A](/filings/0000875357-26-000023.md) | Proxy statement, period 2025-12-31 | 0000875357-26-000023 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000875357-26-000013.md), filed Feb 18, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 875357
- Tickers: BOKF
- Exchange: Nasdaq
- SIC code: 6021 National Commercial Banks
- State of incorporation: OK
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.